Latest Breaking News On - Zuranolone new drug application - Page 1 : comparemela.com

Strong progress toward three potential launches in 2023; Company reports first quarter 2023 results and reaffirms full year 2023 guidance First. | April 25, 2023

Chuck trianoChristophera viehbacherAdam keeneyJack coxSamsung bioepisUs veteran health administrationBiogen incAdvisory committeeExchange commissionHead of corporate developmentNet income attributable to biogen incDevelopment expensePriority reviewHealth administrationSage therapeuticsZuranolone new drug application